Contraceptive Technology Update – January 1, 2018
January 1, 2018
View Issues
-
Time to Update Your Knowledge of Long-Acting Reversible Contraceptives
Practice bulletin says intrauterine, implant options are safe and effective for almost all women.
-
Intrauterine Device Use Linked With Decrease in Cervical Cancer Incidence
Results of a just-published systematic review indicate that in women who used an intrauterine device, the incidence of cervical cancer was one-third lower.
-
Research Update: Human Papillomavirus Vaccine Safe for Adult Women
In a study of more than 3 million adult women in Denmark and Sweden, results indicate that human papillomavirus (HPV) vaccination was not connected with 44 serious chronic diseases.
-
Counsel Women About Contraception Guidelines After Bariatric Surgery
Just-published research indicates that while women should avoid conception for the first 18 months following bariatric surgery, 42% of women participating in the 10-site study reported having unprotected intercourse during the 18-month at-risk, post-surgical timeframe.
-
Griffithsin Considered as Potential Multipurpose Prevention Technology Option
Researchers now are focusing on an investigational multipurpose prevention technology comprised of griffithsin in a carrageenan gel. While research is in the early stages, the combination approach may lead to a new option to prevent HIV and STIs in an on-demand or sustained use format.
-
New Rules Undermine Federal Contraceptive Coverage Guarantee
The regulations leave the coverage guarantee in place, but greatly extend exemptions.